|
 |
REVIEW ARTICLE |
|
Year : 2014 | Volume
: 6
| Issue : 2 | Page : 101-106 |
|
|
Laparoscopic radical and partial nephrectomy: The clinical efficacy and acceptance of the techniques
Abdulrahman Al-Aown1, Panagiotis Kallidonis2, Stavros Kontogiannis2, Iason Kyriayis2, Vasilis Panagopoulos2, Jens-Uwe Stolzenburg3, Evangelos Liatsikos2
1 Department of Urology, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia 2 Department of Urology, University of Patras, Greece 3 Department of Urology, University of Leipzig, Germany
Date of Submission | 18-Dec-2013 |
Date of Acceptance | 10-Feb-2014 |
Date of Web Publication | 15-Apr-2014 |
Correspondence Address: Abdulrahman Al-Aown P. O. Box: 11740, Abha 61321 Saudi Arabia
  | Check |
DOI: 10.4103/0974-7796.130521 PMID: 24833817
Abstract | | |
The laparoscopic approach has been established as the surgical procedure of choice for radical nephrectomy during the recent years. The advantages of the laparoscopic radical nephrectomy in comparison to the open approach are well-documented. The oncological results of the laparoscopic approach are similar to the open procedure while the post-operative morbidity is lower. Laparoscopic partial nephrectomy seems to gain ground to its open counterpart, as the accumulation of experience in the technique grows. In this review, a PubMed search in the latest literature on radical and partial laparoscopic nephrectomy took place and the outcome of the search is presented. Several issues about the surgical techniques and clinical efficacy are discussed. In addition, the preliminary experience in laparoscopic nephrectomy of one of the authoring institutions is also presented. Keywords: Laparoscopic partial nephrectomy, laparoscopic radical nephrectomy, renal cell carcinoma, renal tumors, Saudi Arabia
How to cite this article: Al-Aown A, Kallidonis P, Kontogiannis S, Kyriayis I, Panagopoulos V, Stolzenburg JU, Liatsikos E. Laparoscopic radical and partial nephrectomy: The clinical efficacy and acceptance of the techniques. Urol Ann 2014;6:101-6 |
How to cite this URL: Al-Aown A, Kallidonis P, Kontogiannis S, Kyriayis I, Panagopoulos V, Stolzenburg JU, Liatsikos E. Laparoscopic radical and partial nephrectomy: The clinical efficacy and acceptance of the techniques. Urol Ann [serial online] 2014 [cited 2021 Jan 21];6:101-6. Available from: https://www.urologyannals.com/text.asp?2014/6/2/101/130521 |
Introduction | |  |
Until the introduction of laparoscopic surgery for renal tumors in 1990s, open surgery was the only option for the management of renal tumors. Now-a-days, laparoscopic radical nephrectomy (LRN) is the treatment of choice for T 2 N 0 M 0 tumors. [1] Open partial nephrectomy is still the gold standard for smaller tumors, but laparoscopic partial nephrectomy (LPN) may replace it in the near future. [2]
In this review, the clinical efficacy and outcome as well as technical issues of laparoscopic radical and partial nephrectomy are discussed. The preliminary experience in laparoscopic nephrectomy of the authoring institution in Saudi Arabia is presented.
Lrn | |  |
Background
According to the EAU Guidelines, LRN is the standard of care for T 2 stage tumors. [1] LRN and open radical nephrectomy (ORN) have similar oncological outcomes for these renal tumors. [3],[4] Despite the large experience with LRN, it remains questionable whether this technique is indicated for renal tumors of higher than T3bN0M0. [5] Nevertheless, the technique was proven to be feasible in the case of the aforementioned large tumors. [6],[7] The European Association of Urology recently proposed nephron-sparing surgery (NSS) for T1a and T1b renal tumors, whenever technically feasible. Patients with the above tumors in a solitary kidney have an absolute indication for the OPN. [1] As the laparoscopic experience accumulates world-wide, more indications are applied to the technique. Several technical issues concerning LRN and different approaches follow.
Technical issues
Transperitoneal or retroperitoneal approach?
There are two approaches in LRN: the retroperitoneal and the transperitoneal approach. The transperitoneal approach is considered the access of choice, while the retroperitoneal approach is indicated in patients with intraperitoneal adhesions due to previous abdominal surgery. The retroperitoneal access could also be considered as an alternative to transperitoneal access, as it may be associated with shorter operative time in comparison to its transperitoneal counterpart. [8] The comparison of the retroperitoneal laparoscopic to the open approach showed a complication rate of 17% and a conversion rate of 7% for the laparoscopic cases in a group of tumors of a diameter up to 9 cm. [9] No difference was observed in complication rates and in technical difficulties for the laparoscopic surgeon in a prospective randomized trial comparing the transperitoneal to the retroperitoneal. [8] The oncological outcome has no difference between the two approaches, while advantages regarding the hilar control and the total operative time were documented in the retroperitoneal nephrectomy. [10] Nevertheless, the limited surgical field in the retroperitoneal approach poses a major drawback in this technique. Laparoscopic surgeons are more familiar with the transperitoneal access, as the latter is also used for other procedures such as prostatectomy. [11] In a recent systematic review and meta-analysis, it has been pointed out that the retroperitoneal approach may be faster and equally safe compared with the transperitoneal access. [10] The learning curve of retroperitoneal nephrectomy has been calculated to be 8 cases in a porcine model. [12] The retroperitoneal approach may be more widely acceptable in the future due to the aforementioned advantages.
Hand-assisted approach
It is debatable whether the LRN should be performed by pure laparoscopic or by hand-assisted laparoscopic approach. [13],[14],[15],[16] The hand-assisted radical nephrectomy (HALRN) requires the use of trocars plus a large hand port, while LRN needs only trocars. It has been considered by some investigators that HALRN is the first step of the un-experienced laparoscopic surgeon towards the pure laparoscopic approach. [17] In a meta-analysis that compared the hand-assisted approach to the pure laparoscopic approach, revealed that conversion rates and blood loss were lower in the hand-assisted approach. The cases included both radical and donor nephrectomies. Despite the lower blood loss of the hand-assisted technique, the transfusion rates were similar between both groups and eventually the difference in blood loss was considered to be of no clinical importance. In the hand-assisted technique, the better tactile sensation of the tissues resulted in the lower conversion rates. [18] In a prospective randomized study, the LRN and the HALRN were compared having no difference in the majority of the perioperative parameters. The only difference was the longer convalescence and the longer period required to return to work for the hand-assisted group. [19] Consequently, the experience of the laparoscopic surgeon and the characteristics of each patient are the most important factors in the selection of the appropriate technique.
Clinical efficacy of LRN
In a retrospective non-randomized study, transperitoneal or retroperitoneal LRN and ORN were performed for T2 tumors of approximately 10 cm in diameter. The LRN group had better short-term post-operative results compared to the ORN group and the complication rate was 12% and 15%, respectively. While the mean follow-up was 57 months for ORN and 51 months for LRN, no significant differences were observed in cancer-specific and survival rates. Nonetheless, the laparoscopic surgeon should be experienced in order to perform the operation in such large tumors, as the tumor size was technically challenging. [20]
In a recent prospective study, LRN was compared with ORN regarding T1 or T2 tumors with a maximal diameter of 15 cm. Mean tumor diameter was 5.8 cm for the LRN group and 6.2 cm for the ORN group. LRN was better regarding blood loss during the operation and hospital stay. For a mean follow-up period of 60 months for LRN and 72 months of ORN, cancer-specific survival was 90 and 92%, respectively. Regarding the overall survival, it was 81% for LRN and 79% for ORN. The main advantages of LRN are the better post-operative results, while there was no difference in the oncological outcome between the two procedures. [21]
In a randomized controlled trial comparing LRN and ORN of 45 patients with renal tumors up to 8 cm, the operative time had no significant difference in comparison to ORN and the hospital stay was reported to be 1 day shorter for the LRN. Lower post-operative pain and shorter convalescence period was observed in the LRN group, while the pain was similar between both groups at 3 months post-operatively. [22]
In a comparative study including 336 patients with 7 years follow-up, cancer-specific survival was 92.5% and 91.2% for LRN and ORN, respectively. [9] The selection of the procedure did not influence the oncological outcome, but tumor grade was a significant prognostic factor. In another study of a mean follow-up of 11.2 years, the overall survival rate was 35%, the cancer-specific survival rate was 78% and the recurrence-free survival rate was 77% at 12 years. The oncological outcome of LRN was excellent and did not differ to the oncological outcome of ORN. [23]
Lpn | |  |
Background
Partial nephrectomy is recommended by EAU Guidelines for the management of T1a and T1b renal cell tumors. [1] Absolute indications are cases of anatomic or functional solitary kidney and bilateral renal cell carcinoma (RCC). Decreased function of the contralateral kidney, systemic disease that could influence renal function in the future, hereditary types of RCC associated with risk of tumor development in the contralateral kidney, diabetes, renovascular disease and hypertension are relative indications. Its technical difficulties have made LPN to be an alternative surgical approach to the gold standard open partial nephrectomy (OPN). OPN is the gold standard, but recently it has been challenged by LPN, which in the hands of experts appear to have similar oncological results. [24]
LPN is a challenging procedure. The surgeon that performs it should have the adequate experience and delicate skills. [24] A surgical margin of a few millimeters is required for optimum oncological results. [25] The size of the tumor may represent a challenge for the adequate resection. Thus, T1b tumors are recommended to be under intensive surveillance. Relative contraindications for the laparoscopic approach are: Complex mid-pole intrarenal/hilar tumor in a patient with imperative indication for NSS or previous open surgery on the same side. [11]
Predictive scoring systems for NSS
During the development of the NSS, two predictive scores have been introduced in an attempt to predict complications and surgery related outcome of partial nephrectomy. [26],[27] These scores have been evaluated in LPN. Both scores use radiological and anatomical features such as tumor size and location, morphology characteristics (exophytic or endophytic, involvement of the pelvicalyceal system etc.) and classify the tumors according to their complexity, which is considered to be correlated to perioperative complications. Moreover, these systems allow a consensus in the evaluation of tumors among surgeons. [28] The evaluation of these scores showed that there is not any significant difference among the scoring systems and tumor stage or perioperative complications. [28],[29] Pre-operative aspects and dimensions used for an anatomical score ≥ 10 and RENAL score ≥9 are factors demonstrating a high risk for perioperative complications. [30] An increasing RENAL score is associated with histological features of tumor aggressiveness and a greater proportion of major complications. [31] Correlation between the scoring systems and changes in estimated glomerular filtration rate, creatinine levels and warm ischemia time (WIT) has been reported. [32],[33],[34] In fact, tumors with higher complexity are associated with higher percent change in creatinine levels in comparison the low complexity tumors. [33] The reproducibility of the both scoring systems has been shown to be high. [28]
Technical issues
Transperitoneal versus retroperitoneal LPN
For lesions located anteriorly or laterally, the transperitoneal approach is used. The retroperitoneal approach has been associated with better outcomes for posterior tumors. [35] Transperitoneal LPN was used in larger tumors and was linked with more pelvicaliceal repairs and longer WIT, operative time and hospital stay compared to retroperitoneal LPN. No significant difference was observed between the two approaches in perioperative complications, post-operative pain, post-operative renal function and estimated blood loss. [35],[36]
Hemostasis
Hilar clamping is the most commonly used method to achieve a bloodless surgical field. During tumor excision, it is also very difficult to minimize the blood loss. One of the methods proposed is the percutaneous radiofrequency (RF) coagulation. RF results in a spherical coagulation area 1 cm around the lesion. Cold scissors or ultrasound shears are used to resect the tumor and reduce the blood loss. The major complications of the RF coagulation were the collateral damage of renal vasculature and collecting system, delayed urinary fistula and difficulty to distinguish the tumor margin. [37],[38] Monopolar RF device made LPN possible without clamping the renal vessels. This device provides simultaneous dissection, hemostasis and coagulation. Mean tumor size and mean estimated blood loss was 3.9 cm and 352 ml, respectively. [38]
The hemostatic sealant Floseal (Baxter Healthcare, USA) is another product that provides hemostasis of the surgical field of LPN. It is composed of a cross-linked gelatin granules and topical thrombin glue. When Floseal was used, significant overall complications and hemorrhages were less frequent. [39] Floseal is placed at the site of the sutured renal incision at the end of the procedure. Several other bioglues have been used, such as fibrin glue (Tisseel; Baxter), bovine serum albumin-based adhesive (BioGlue; CryoLife), cyanoacrylate glue (Glubran; General Enterprise Marketing) and other hemostatic agents. All these agents have been evaluated in a multi-institutional study with 1347 cases of LPN. [40] The benefit of these agents is not well proven and should be used to control minor bleeding in conjunction with other measures such as parenchymal suturing over a bolster.
Hilar control and warm ischemia
Post-operative renal function is very important after a partial nephrectomy and is determined primarily by three factors: pre-operative renal function, volume of renal mass preserved and surgical renal ischemia. Minimization of surgical ischemia is achieved by early unclamping and unclamped (zero ischemia) techniques. A variety of methods have tried to achieve hilar control and shorter WIT. The most frequently used method is the clamping of renal vessels. Clamping only the renal artery or intermittent clamping has been used also. WIT of no more than 30 min seems to be really important for the post-operative renal function. [25] Nevertheless, there is no adequate evidence to decide which method is the most appropriate. WIT of more than 60 min has been reported and is not proven to be related to permanent renal function damage, while an average WIT of 22.5 min (range 10-44 min) was not associated with any renal function and glomerular filtration deterioration. [41]
Desai et al. studied 179 patients who underwent LPN. A solitary kidney has been reported in 19 patients, where the average WIT was 29 min and an average of 29% of the kidney was excised. Renal scintigraphy was used to measure the renal function in patients with both kidneys and it has been shown that there has been a reduction in 29% in the operated kidney. WIT of 30 min has been associated with no important deterioration in renal function. Consequently, it is recommended to keep the WIT less than 30 min. [42]
Another technique to reduce the ischemia time is the early unclamping of the renal vessels. The unclamping takes place right after the first parenchymal suturing and the remaining sutures are done without vessel clamping. The early unclamping has significantly reduced ischemia time to half. Similar results were confirmed also by other studies. [43]
Another method to reduce the effects of warm ischemia is the placement of thrombin gel slurry to the renal lesion after tumors excision. The gel is pressed on the injured surface of the kidney by a sponge stick for 1-2 min and then the renal vessels are unclamped. The results were 13 min of WIT and 200 ml of estimated blood loss on average. [44]
Zero ischemia has been also tried lately with good results. LPN without hilar clamping is feasible, safe and associated with less renal injury as assessed by post-operative glomerular filtration rate in select patients. [45],[46] With experience, it can be applied to complex renal lesions.
Renal hypothermia
A method to reduce the complications of renal ischemia is the intracorporeal hypothermia to the surface of the renal parenchyma. The renal vessels are clamped and an endoscopic bag is filled with 600-750 ml of ice. The renal temperature ranged between 5°C and 19°C. [47] Another method to achieve renal hypothermia consists of perfusing the renal parenchyma with a 4°C solution by an angiocatheter placed peripherally of the clamp occlusion. A mean temperature of 25°C was shown in the renal parenchyma. Nevertheless, this is not satisfactory, as the optimal hypothermia temperature is below 15°C. [48] Another way to cause renal hypothermia is to perfuse the kidney with cold saline through a ureteral sheath. Again, the temperatures that were demonstrated were not adequate to prevent serious renal damage (24°C for the renal cortex and 21°C for the renal medulla). [49] The clinical use of renal hypothermia to reduce the ischemia related renal damage remains to be proven by further studies. Further technical details have to be improved in order to see the widespread distribution of these techniques.
Pelvicaliceal repair
The opening of the pelvicaliceal system of the kidney is associated with longer WIT and longer hospitalization. Nevertheless, urinary leakage is not a common complication when repair of the pelvicalyceal system is performed. While ureteral stents do not alter the natural history of the urinary leakage, the use of these stents is indicated in the following cases: (1) To specify the site of the pelvicaliceal entry (there may be more than one entries); (2) to test the tightness of the pelvicaliceal repair by retrograde injection. [50]
Clinical efficacy of LPN
LPN and open partial nephrectomy have been compared in order to find the advantages of each approach. LPN is linked with less blood loss and shorter hospital stay. [51] In addition, operative time has been controversially reported to be either longer or shorter for the open approach. Nevertheless, the cases treated by LPN presented tumors of smaller size and the advantages in operative time should probably be attributed to this. [52] The two approaches did not show differences in the oncological outcome which was similar after long-term follow-up. [53],[54] The learning curve played a significant role in the beginning of the laparoscopic experience and higher complication rates were obserevd. After the accumulated experience, the complication rates were similar to the two approaches. [51] Currently, the outcome of LPN concerning WIT, post-operative complications and post-operative renal function seems to be improving and matching the results of OPN.
The initial experience in laparoscopic nephrectomy of the Saudi Arabian author in this review.
Twenty-five patients underwent transperitoneal laparoscopic nephrectomy in a year (April 2011-April 2012). The nephrectomy was performed by a urologist who was trained in a program dedicated to endoscopy and laparoscopy and the current series represents his first experience in his institution. The mean age of the treated patients was 43 years old (range 7-59). 16 (64%) of them were men and 9 (36%) were women. The indications for nephrectomy included patients with non-functioning kidneys in 60% of the cases, while a renal mass was diagnosed in 24% of the cases. The demographics of the patients are summarized in [Table 1].
All data for the above series were prospectively recorded and the follow-up period was 1 year. The average operation time was 2.5 h (range 2-3 h) and hospitalization time ranged between 3 and 5 days, with an average of 4.5 days. Blood transfusion was performed in 2 patients (8%). The histologic findings along with other perioperative details and rates of post-operative complications are presented in [Table 2]. Two post-operative complications were encountered: A retroperitoneal hematoma, which was treated conservatively and an incisional hernia, which was treated by a mesh placement (Clavien classification grades II and IIIb respectively [55] ). Conversion to open approach was never necessary. | Table 2: Perioperative outcome, histopathology and complications of the current series
Click here to view |
The initial experience showed promising results for the future. Operative time and complication rates are comparable to those presented in literature despite the presence of a portion of the learning curve in the current series. With increasing experience, the results would probably improve and the transition from open surgery to laparoscopy would be possible.
Conclusion | |  |
LRN has been established as the gold standard for renal tumors with improved outcomes in comparison to ORN. LPN is still under clinical evaluation and the continuous development shows that the technique will eventually be established as a standard method for the management of small renal tumors in the future. Urological research seems to work continuously towards the latter aim by providing new concepts and technical tools to the laparoscopic armamentarium.
References | |  |
1. | Ljungberg B, Dabestani S, Marconi L, Volpe A. Eau Guidelines; Guidelines on Renal Cell Carcinoma. Milan: EAU; 2013.  |
2. | Mottrie A, Borghesi M, Ficarra V. Is traditional laparoscopy the real competitor of robot-assisted partial nephrectomy? Eur Urol 2012;62:1034-6.  [PUBMED] |
3. | Eskicorapci SY, Teber D, Schulze M, Ates M, Stock C, Rassweiler JJ. Laparoscopic radical nephrectomy: The new gold standard surgical treatment for localized renal cell carcinoma. ScientificWorldJournal 2007;7:825-36.  |
4. | Shuford MD, McDougall EM, Chang SS, LaFleur BJ, Smith JA Jr, Cookson MS. Complications of contemporary radical nephrectomy: Comparison of open vs. laparoscopic approach. Urol Oncol 2004;22:121-6.  |
5. | Alvarez-Maestro M, Ríos E, Martínez-Piñeiro L, Díez J, Sánchez FJ, Linares A. Limits of laparoscopic radical nephrectomy. Arch Esp Urol 2013;66:168-79.  |
6. | Pautler SE, Walther MM. Laparoscopic radical nephrectomy for advanced kidney cancer. Curr Urol Rep 2002;3:21-4.  |
7. | Stewart GD, Ang WJ, Laird A, Tolley DA, Riddick AC, McNeill SA. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer. BJU Int 2012;110:884-90.  |
8. | Desai MM, Strzempkowski B, Matin SF, Steinberg AP, Ng C, Meraney AM, et al. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol 2005;173:38-41.  |
9. | Abbou CC, Cicco A, Gasman D, Hoznek A, Antiphon P, Chopin DK, et al. Retroperitoneal laparoscopic versus open radical nephrectomy. J Urol 1999;161:1776-80.  |
10. | Fan X, Xu K, Lin T, Liu H, Yin Z, Dong W, et al. Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: A systematic review and meta-analysis. BJU Int 2013;111:611-21.  |
11. | Liatsikos E, Kallidonis P, Do M, Dietel A, Al-Aown A, Constantinidis C, et al. Laparoscopic radical and partial nephrectomy: Technical issues and outcome. World J Urol 2013;31:785-91.  |
12. | Hisano M, Duarte RJ, Colombo JR Jr, Srougi M. Is there a model to teach and practice retroperitoneoscopic nephrectomy? Minim Invasive Ther Allied Technol 2013;22:33-8.  |
13. | Bandi G, Christian MW, Hedican SP, Moon TD, Nakada SY. Oncological outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: A single-institution study with > or = 3 years of follow-up. BJU Int 2008;101:459-62.  |
14. | Harano M, Eto M, Yokomizo A, Tatsugami K, Hamaguchi M, Naito S. Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma. Fukuoka Igaku Zasshi 2007;98:389-96.  |
15. | Klop KW, Kok NF, Dols LF, d′Ancona FC, Adang EM, Grutters JP, et al. Cost-effectiveness of hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: A randomized study. Transplantation 2013;96:170-5.  |
16. | Wadström J, Martin AL, Estok R, Mercaldi CJ, Stifelman MD. Comparison of hand-assisted laparoscopy versus open and laparoscopic techniques in urology procedures: A systematic review and meta-analysis. J Endourol 2011;25:1095-104.  |
17. | Sterrett SP, Nakada SY. Hand-assisted radical laparoscopic nephrectomy. BJU Int 2008;102:404-15.  |
18. | Silberstein J, Parsons JK. Hand-assisted and total laparoscopic nephrectomy: A comparison. JSLS 2009;13:36-43.  |
19. | Venkatesh R, Belani JS, Chen C, Sundaram CP, Bhayani SB, Figenshau RS, et al. Prospective randomized comparison of laparoscopic and hand-assisted laparoscopic radical nephrectomy. Urology 2007;70:873-7.  |
20. | Hemal AK, Kumar A, Kumar R, Wadhwa P, Seth A, Gupta NP. Laparoscopic versus open radical nephrectomy for large renal tumors: A long-term prospective comparison. J Urol 2007;177:862-6.  |
21. | Colombo JR Jr, Haber GP, Aron M, Cocuzza M, Colombo R, Kaouk J, et al. Oncological outcomes of laparoscopic radical nephrectomy for renal cancer. Clinics (Sao Paulo) 2007;62:251-6.  |
22. | Burgess NA, Koo BC, Calvert RC, Hindmarsh A, Donaldson PJ, Rhodes M. Randomized trial of laparoscopic v open nephrectomy. J Endourol 2007;21:610-3.  |
23. | Berger A, Brandina R, Atalla MA, Herati AS, Kamoi K, Aron M, et al. Laparoscopic radical nephrectomy for renal cell carcinoma: Oncological outcomes at 10 years or more. J Urol 2009;182:2172-6.  |
24. | Sharma V, Margreiter M. Partial nephrectomy: Is there still a need for open surgery? Curr Urol Rep 2013;14:1-4.  |
25. | Leslie S, Goh AC, Gill IS. Partial nephrectomy - Contemporary indications, techniques and outcomes. Nat Rev Urol 2013;10:275-83.  |
26. | Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 2009;56:786-93.  |
27. | Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009;182:844-53.  |
28. | Zhang ZY, Tang Q, Li XS, Zhang Q, Mayer WA, Wu JY, et al. Clinical analysis of the PADUA and the RENAL scoring systems for renal neoplasms: A retrospective study of 245 patients undergoing laparoscopic partial nephrectomy. Int J Urol 2014;21:40-4.  |
29. | Long JA, Arnoux V, Fiard G, Autorino R, Descotes JL, Rambeaud JJ, et al. External validation of the RENAL nephrometry score in renal tumours treated by partial nephrectomy. BJU Int 2013;111:233-9.  |
30. | Hew MN, Baseskioglu B, Barwari K, Axwijk PH, Can C, Horenblas S, et al. Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. J Urol 2011;186:42-6.  |
31. | Ellison JS, Montgomery JS, Hafez KS, Miller DC, He C, Wolf JS Jr, et al. Association of RENAL nephrometry score with outcomes of minimally invasive partial nephrectomy. Int J Urol 2013;20:564-70.  |
32. | Kong W, Zhang J, Dong B, Chen Y, Xue W, Liu D, et al. Application of a standardized anatomical classification in a Chinese partial nephrectomy series. Int J Urol 2012;19:551-8.  |
33. | Okhunov Z, Rais-Bahrami S, George AK, Waingankar N, Duty B, Montag S, et al. The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol 2011;25:1921-4.  |
34. | Waldert M, Waalkes S, Klatte T, Kuczyk MA, Weibl P, Schüller G, et al. External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery. World J Urol 2010;28:531-5.  |
35. | Ng CS, Gill IS, Ramani AP, Steinberg AP, Spaliviero M, Abreu SC, et al. Transperitoneal versus retroperitoneal laparoscopic partial nephrectomy: Patient selection and perioperative outcomes. J Urol 2005;174:846-9.  |
36. | Marszalek M, Chromecki T, Al-Ali BM, Meixl H, Madersbacher S, Jeschke K, et al. Laparoscopic partial nephrectomy: A matched-pair comparison of the transperitoneal versus the retroperitoneal approach. Urology 2011;77:109-13.  |
37. | Gettman MT, Bishoff JT, Su LM, Chan D, Kavoussi LR, Jarrett TW, et al. Hemostatic laparoscopic partial nephrectomy: Initial experience with the radiofrequency coagulation-assisted technique. Urology 2001;58:8-11.  |
38. | Urena R, Mendez F, Woods M, Thomas R, Davis R. Laparoscopic partial nephrectomy of solid renal masses without hilar clamping using a monopolar radio frequency device. J Urol 2004;171:1054-6.  |
39. | Wille AH, Johannsen M, Miller K, Deger S. Laparoscopic partial nephrectomy using FloSeal for hemostasis: Technique and experiences in 102 patients. Surg Innov 2009;16:306-12.  |
40. | Breda A, Stepanian SV, Lam JS, Liao JC, Gill IS, Colombo JR, et al. Use of haemostatic agents and glues during laparoscopic partial nephrectomy: A multi-institutional survey from the United States and Europe of 1347 cases. Eur Urol 2007;52:798-803.  |
41. | Aron M, Gill IS. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours part I: Laparoscopic partial nephrectomy. Eur Urol 2007;51:337-46.  |
42. | Desai MM, Gill IS, Ramani AP, Spaliviero M, Rybicki L, Kaouk JH. The impact of warm ischaemia on renal function after laparoscopic partial nephrectomy. BJU Int 2005;95:377-83.  |
43. | Breda A, Finelli A, Janetschek G, Porpiglia F, Montorsi F. Complications of laparoscopic surgery for renal masses: Prevention, management, and comparison with the open experience. Eur Urol 2009;55:836-50.  |
44. | Bak JB, Singh A, Shekarriz B. Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. J Urol 2004;171:780-2.  |
45. | George AK, Herati AS, Srinivasan AK, Rais-Bahrami S, Waingankar N, Sadek MA, et al. Perioperative outcomes of off-clamp vs complete hilar control laparoscopic partial nephrectomy. BJU Int 2013;111:E235-41.  |
46. | Tanagho YS, Bhayani SB, Sandhu GS, Vaughn NP, Nepple KG, Figenshau RS. Renal functional and perioperative outcomes of off-clamp versus clamped robot-assisted partial nephrectomy: Matched cohort study. Urology 2012;80:838-43.  |
47. | Gill IS, Abreu SC, Desai MM, Steinberg AP, Ramani AP, Ng C, et al. Laparoscopic ice slush renal hypothermia for partial nephrectomy: The initial experience. J Urol 2003;170:52-6.  |
48. | Janetschek G, Abdelmaksoud A, Bagheri F, Al-Zahrani H, Leeb K, Gschwendtner M. Laparoscopic partial nephrectomy in cold ischemia: Renal artery perfusion. J Urol 2004;171:68-71.  |
49. | Landman J, Venkatesh R, Lee D, Vanlangendonck R, Morissey K, Andriole GL, et al. Renal hypothermia achieved by retrograde endoscopic cold saline perfusion: Technique and initial clinical application. Urology 2003;61:1023-5.  |
50. | Berger A, Crouzet S, Canes D, Haber GP, Gill IS. Minimally invasive nephron-sparing surgery. Curr Opin Urol 2008;18:462-6.  |
51. | Lucas SM, Mellon MJ, Erntsberger L, Sundaram CP. A comparison of robotic, laparoscopic and open partial nephrectomy. JSLS 2012;16:581-7.  |
52. | Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-6.  |
53. | Lane BR, Gill IS. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol 2010;183:473-9.  |
54. | Zheng JH, Zhang XL, Geng J, Guo CC, Zhang XP, Che JP, et al. Long-term oncologic outcomes of laparoscopic versus open partial nephrectomy. Chin Med J (Engl) 2013;126:2938-42.  |
55. | Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.  |
[Table 1], [Table 2]
|